K2 Principal Fund, L.P. Profound Medical Corp. Transaction History
K2 Principal Fund, L.P.
- $307 Million
- Q4 2024
A detailed history of K2 Principal Fund, L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 35,782 shares of PROF stock, worth $267,649. This represents 0.09% of its overall portfolio holdings.
Number of Shares
35,782
Previous 50,000
28.44%
Holding current value
$267,649
Previous $398,000
32.66%
% of portfolio
0.09%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding PROF
# of Institutions
56Shares Held
13.6MCall Options Held
3.9KPut Options Held
1.4K-
Fil LTD Hamilton, D01.8MShares$13.4 Million0.01% of portfolio
-
Gagnon Securities LLC1.65MShares$12.4 Million2.68% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.21MShares$9.06 Million0.18% of portfolio
-
Timelo Investment Management Inc.912KShares$6.82 Million4.82% of portfolio
-
Gagnon Advisors, LLC897KShares$6.71 Million4.87% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $156M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...